期刊文献+
共找到16篇文章
< 1 >
每页显示 20 50 100
Synthesis and anti-HIV-1 activity evaluation of N-1-alkyl-5-halogeno-6-alkylamino uracils as novel non-nucleoside HIV-1 reverse transcriptase inhibitors
1
作者 闫寒 王孝伟 +2 位作者 郭盈 张志丽 刘俊义 《Journal of Chinese Pharmaceutical Sciences》 CAS 2011年第2X期146-153,共8页
N-1-alkyl-5-halogeno-6-alkylamino uracils,which are novel 1-[(2-hydroxyethoxy) methyl]-6-(phenylthio) thymine (HEPT) analogues,were synthesized as the selective and potent non-nucleoside human immunodeficiency virus(H... N-1-alkyl-5-halogeno-6-alkylamino uracils,which are novel 1-[(2-hydroxyethoxy) methyl]-6-(phenylthio) thymine (HEPT) analogues,were synthesized as the selective and potent non-nucleoside human immunodeficiency virus(HIV)-1 reverse transcriptase inhibitors.Some of the compounds showed potent inhibitory activity against HIV-1 reverse transcriptase.For instance,compounds 1d,1m and 1n exhibited potent anti-HTV-1 activity with the IC_(50) values of 13.3,11.7 and 3.15μM,respectively, which are comparable to that of nevirapine(IC_(50) 8.38μM). 展开更多
关键词 hiv-1 reverse transcriptase Non-nucleoside reverse transcriptase inhibitors HEPT analogues
原文传递
Synthesis and biological evaluation of novel 1-aryl-5-iodo-6-benzyluracils as potent HIV-1 non-nucleoside reverse transcriptase inhibitors
2
作者 王惟 李立 +5 位作者 刘畅 张亮 闫寒 张志丽 王孝伟 刘俊义 《Journal of Chinese Pharmaceutical Sciences》 CAS 2010年第4期312-317,共6页
We have synthesized the novel compounds 1a-1i,which are a series of hybrid analogues to 6-benzyl-1-(benzyloxymethyl)- 5-iodouracil,a compound showing strong activity against HIV-1.We also evaluated the activity of t... We have synthesized the novel compounds 1a-1i,which are a series of hybrid analogues to 6-benzyl-1-(benzyloxymethyl)- 5-iodouracil,a compound showing strong activity against HIV-1.We also evaluated the activity of these compounds as the inhibitors of HIV-1 reverse transcriptase(HIV-1 RT),and they have demonstrated moderate activity. 展开更多
关键词 hiv-1 reverse transcriptase Non-nucleoside reverse transcriptase inhibitors l-[(2-Hydroxyethoxy)methyl]-6-phenylthiothymine
原文传递
Synthesis and biological evaluation of novel 2-arylalkylthio-5-iodo-6-benzyl S-DABOs as potent non-nucleoside HIV-1 reverse transcriptase inhibitors 被引量:1
3
作者 Liang Zhang Xiao-Wei Wang Jun-Yi Liu 《Journal of Chinese Pharmaceutical Sciences》 CAS 2012年第1期28-32,共5页
A series of novel dihydro-alkylthio-benzyl-oxopyrimidines (S-DABOs) 7a-f have been designed and synthesized with an efficient method. Biological evaluation of their HIV-1 reverse transcriptase inhibitory activities ... A series of novel dihydro-alkylthio-benzyl-oxopyrimidines (S-DABOs) 7a-f have been designed and synthesized with an efficient method. Biological evaluation of their HIV-1 reverse transcriptase inhibitory activities was performed using Nevirapine (NVP) as a reference compound. Among the series, compound 7d shows the highest reverse transcriptase inhibitory activity, which is better than Nevirapine. 展开更多
关键词 hiv-1 RT Non-nucleoside reverse transcriptase inhibitors S-DABOs
原文传递
Synthesis and anti-HIV-1 activity evaluation of N-l-alkyl-5-halogeno-6- alkylamino uracils as novel non-nucleoside HIV-I reverse transcriptase inhibitors
4
作者 Han Yan Xiao-Wei Wang +2 位作者 Ying Guo Zhi-Li Zhang Jun-Yi Liu 《Journal of Chinese Pharmaceutical Sciences》 CAS 2011年第2期146-153,共8页
N-l-alkyl-5-halogeno-6-alkylamino uracils, which are novel l-[(2-hydroxyethoxy) methyl]-6-(phenylthio) thymine (HEPT) analogues, were synthesized as the selective and potent non-nucleoside human immunodeficiency... N-l-alkyl-5-halogeno-6-alkylamino uracils, which are novel l-[(2-hydroxyethoxy) methyl]-6-(phenylthio) thymine (HEPT) analogues, were synthesized as the selective and potent non-nucleoside human immunodeficiency virus (HIV)-I reverse transcriptase inhibitors. Some of the compounds showed potent inhibitory activity against HIV-1 reverse transcriptase. For instance, compounds ld, lm and In exhibited potent anti-HIV-1 activity with the ICso values of 13.3, 11.7 and 3.15 μM, respectively, which are comparable to that of nevirapine (IC50 8.38 μM). 展开更多
关键词 hiv-1 reverse transeriptase Non-nucleoside reverse transcriptase inhibitors HEPT analogues
原文传递
Characterization of Genotypic Mutations and Antiretroviral Resistance among Viremic HIV-Infected Patients in a High HIV Prevalence Area: Treatment Challenge and Transmission Risk
5
作者 AliAsad Arastu Virginia Kan 《World Journal of AIDS》 2011年第3期70-77,共8页
There have been few reports evaluating the prevalence of genotypic mutations and antiretroviral resistance among chronic HIV-infected Veterans within the United States. This retrospective cross-sectional study charact... There have been few reports evaluating the prevalence of genotypic mutations and antiretroviral resistance among chronic HIV-infected Veterans within the United States. This retrospective cross-sectional study characterizes the rates and changes in HIV genotypic mutations and antiretroviral resistance among viremic patients from 2001 to 2006 at the VA Medical Center located in Washington, DC. The District of Columbia is the metropolitan area with the highest HIV prevalence within the United States. De-identified, linked HIV RNA, genotypic reverse transcriptase (RT) and protease (Pr) mutations and antiretroviral resistance results were assessed for changes during the 6-year period. Aggregated clinic and antiretroviral utilization, and HIV acquisition risk data were evaluated for patients in care during this time. Among 990 viremic samples, the rate of any detected RT or Pr mutation fell from 100% in 2001 to 95% in 2006. This was primarily attributable to the 15% - 20% decrease seen for RT gene mutations against nucleoside/nucleotide class and non-nucleoside class during this period. Resistance to didanosine, stavudine, zidovudine, nevirapine and efavirenz decreased, and tenofovir resistance increased. Despite stable rates of Pr gene mutations, atazanavir resistance increased by 22% from 2003 to 2006. Some but not all changes in genotypic mutations and resistance patterns reflected our patients’ antiretroviral drug utilization. As sexual contacts (77%) and injection drug use (22%) were the leading acquisition risks disclosed by our HIV-infected patients, the high prevalence and changing patterns of HIV genotypic mutations and drug resistance among these patients have had pivotal impacts not only on HIV treatment but potential transmission into our community. 展开更多
关键词 HIV Viremia ANTIRETROVIRAL Resistance GENOTYPIC ANTIRETROVIRAL MUTATIONS Transmission Nucleoside/nucleotide reverse transcriptase inhibitors NON-NUCLEOSIDE reverse transcriptase inhibitors Protease inhibitors
下载PDF
Design, synthesis and activity evaluation of novel pyridinone derivatives as anti-HIV-1 dual(RT/IN) inhibitors 被引量:1
6
作者 Quanzhi Yang Tao Sheng +7 位作者 Ningning Fan Yameng Hao Yuanyuan Cao Ying Guo Zhili Zhang Chao Tian Junyi Liu Xiaowei Wang 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2017年第1期31-44,共14页
Three series of novel anti-immunodeficiency virus 1 (HIV-1) dual (RT/1N) inhibitors were rationally designed by introducing a functioning diketo acid (DKA) into pyridin-2-one scaffold. To efficiently analyze inh... Three series of novel anti-immunodeficiency virus 1 (HIV-1) dual (RT/1N) inhibitors were rationally designed by introducing a functioning diketo acid (DKA) into pyridin-2-one scaffold. To efficiently analyze inhibitory activity, these compounds were screened against HIV-1 RT and IN respectively via surface plasmon resonance (SPR), and active compounds were subsequently evaluated by enzyme assay. It was noteworthy that compound A2 exhibited moderate activity against both HIV-1 RT and IN. This result provided information for further development of pyridinone analogues as potent dual HIV-1 inhibitors. 展开更多
关键词 Pyridinone derivatives hiv-1 dual inhibitor reverse transcriptase INTEGRASE
原文传递
HIV非核苷酸逆转录酶抑制剂的合成
7
作者 王奕程 《山西化工》 CAS 2024年第1期37-41,共5页
获得性免疫缺陷综合症作为一种无声、致命的杀手,是当今世界最为严重的传染性疾病之一。逆转录酶是HIV病毒增殖所需的重要蛋白质,目前非核苷酸逆转录酶抑制剂以其较高的特异性而被广泛采用。本文将关注于三种经典的HIV非核苷酸逆转录酶... 获得性免疫缺陷综合症作为一种无声、致命的杀手,是当今世界最为严重的传染性疾病之一。逆转录酶是HIV病毒增殖所需的重要蛋白质,目前非核苷酸逆转录酶抑制剂以其较高的特异性而被广泛采用。本文将关注于三种经典的HIV非核苷酸逆转录酶抑制剂Rilpivirine、Etravirine以及Doravirine的化学合成,从最初产率较低、耗时较长的合成出发,通过采用微波辐射、正交实验以及有机金属催化反应达到合成最优化的目的。最优化的过程不仅仅局限于对反应路线的改进,还有在反应路线的基础上小尺度地对反应参数的最优化。 展开更多
关键词 有机合成 有机合成最优化 获得性免疫缺陷综合症 非核苷酸逆转录酶抑制剂
下载PDF
富马酸泰诺福韦酯新合成路线 被引量:12
8
作者 武卫 唐磊 +2 位作者 邓银来 顾维 张荣久 《中国药科大学学报》 CAS CSCD 北大核心 2010年第6期505-507,共3页
对富马酸泰诺福韦酯的新合成路线进行研究。以R-环氧氯丙烷为起始原料,通过常压氢化制得R-1-氯-2-丙醇(7),化合物7与多聚甲醛和氯化氢气体反应得R-1-氯-2-氯甲基丙烷(6),化合物6与亚磷酸三乙酯反应得R-(2-甲基-1-氯乙基)氧甲基膦酸二乙... 对富马酸泰诺福韦酯的新合成路线进行研究。以R-环氧氯丙烷为起始原料,通过常压氢化制得R-1-氯-2-丙醇(7),化合物7与多聚甲醛和氯化氢气体反应得R-1-氯-2-氯甲基丙烷(6),化合物6与亚磷酸三乙酯反应得R-(2-甲基-1-氯乙基)氧甲基膦酸二乙酯(5),化合物5与腺嘌呤缩合后再经脱酯反应得到关键中间体R-9-(2-膦酸甲氧基丙基)-腺嘌呤(3,泰诺福韦)。化合物3经酯化、成盐得到最终产物富马酸泰诺福韦酯。合成富马酸泰诺福韦酯的总收率为8.4%,其结构经MS、1HNMR和IR确证。 展开更多
关键词 核苷酸逆转录酶抑制剂 泰诺福韦 富马酸泰诺福韦酯 合成 新合成路线
下载PDF
核苷酸类逆转录酶抑制剂的进展与评价 被引量:4
9
作者 张石革 《中国医院用药评价与分析》 2005年第5期270-273,共4页
目的:回顾核苷酸类逆转录酶抑制剂的研究进展,并评价其临床疗效和安全性,以期为临床合理用药提供参考。方法:采用近期国内、外文献综述方法。结果与结论:自20世纪60年代相继发现了病毒的逆转录酶、蛋白酶、整合酶,启迪着医药学者为对抗... 目的:回顾核苷酸类逆转录酶抑制剂的研究进展,并评价其临床疗效和安全性,以期为临床合理用药提供参考。方法:采用近期国内、外文献综述方法。结果与结论:自20世纪60年代相继发现了病毒的逆转录酶、蛋白酶、整合酶,启迪着医药学者为对抗病毒而择选新的切入靶位,也标志着药物联合治疗(鸡尾酒疗法)治疗获得性免疫缺乏综合征(艾滋病)的开始。逆转录酶抑制剂可抑制人体免疫缺陷病毒的感染,为治疗获得性免疫缺乏综合征提供了全新效果,受得临床医师和患者的青睐,成为维系艾滋病患者生命的纽带。 展开更多
关键词 人体免疫缺陷病毒 获得性免疫缺乏综合征(艾滋病) 核苷酸逆转录酶抑制剂 研究进展 应用
下载PDF
Synthesis and anti-HIV activities of phorbol derivatives
10
作者 HUANG Xiaolei TANG Chengrun +9 位作者 HUANG Xusheng YANG Yun LI Qirun MA Mengdi ZHAO Lei YANG Liumeng CUI Yadong ZHANG Zhenqing ZHENG Yongtang ZHANG Jian 《Chinese Journal of Natural Medicines》 SCIE CAS CSCD 2024年第2期146-160,共15页
In this study,37 derivatives of phorbol esters were synthesized and their anti-HIV-1 activities evaluated,building upon our previous synthesis of 51 phorbol derivatives.12-Para-electron-acceptor-trans-cinnamoyl-13-dec... In this study,37 derivatives of phorbol esters were synthesized and their anti-HIV-1 activities evaluated,building upon our previous synthesis of 51 phorbol derivatives.12-Para-electron-acceptor-trans-cinnamoyl-13-decanoyl phorbol derivatives stood out,demonstrating remarkable anti-HIV-1 activities and inhibitory effects on syncytia formation.These derivatives exhibited a higher safety index compared with the positive control drug.Among them,12-(trans-4-fluorocinnamoyl)-13-decanoyl phorbol,designated as compound 3c,exhibited the most potent anti-HIV-1 activity(EC_(50)2.9 nmol·L^(−1),CC50/EC_(50)11117.24)and significantly inhibited the formation of syncytium(EC_(50)7.0 nmol·L^(−1),CC50/EC_(50)4891.43).Moreover,compound 3c is hypothesized to act both as an HIV-1 entry inhibitor and as an HIV-1 reverse transcriptase inhibitor.Isothermal titration calorimetry and molecular docking studies indicated that compound 3c may also function as a natural activator of protein kinase C(PKC).Therefore,compound 3c emerges as a potential candidate for developing new anti-HIV drugs. 展开更多
关键词 Phorbol esters Anti-hiv-1 activity Syncytia formation 12-(Trans-4-fluorocinnamoyl)-13-decanoyl phorbol Safety index hiv-1 entry inhibitor hiv-1 reverse transcriptase inhibitor PKC activator
原文传递
富马酸替诺福韦二吡呋酯的质谱分析及NMR测定富马酸相对含量 被引量:2
11
作者 周海云 陈晓红 +1 位作者 李玮 关山越 《药物分析杂志》 CAS CSCD 北大核心 2012年第12期2180-2183,共4页
目的:利用电子轰击(EI)质谱进行分析,得到富马酸替诺福韦二吡呋酯(TDF)的质谱特征;建立核磁共振氢谱(1H-NMR)的方法分析富马酸与替诺福韦二吡呋酯的结合比例。方法:采用EI质谱对富马酸替诺福韦二吡呋酯进行分析,对质谱主要碎片峰进行归... 目的:利用电子轰击(EI)质谱进行分析,得到富马酸替诺福韦二吡呋酯(TDF)的质谱特征;建立核磁共振氢谱(1H-NMR)的方法分析富马酸与替诺福韦二吡呋酯的结合比例。方法:采用EI质谱对富马酸替诺福韦二吡呋酯进行分析,对质谱主要碎片峰进行归属;在对药物进行结构分析的基础上利用1H-NMR信号强度与质子数成正比的特点,对化合物中富马酸的相对含量进行定量分析。结果:EI质谱特征证明所检测化合物所结合的有机酸为富马酸,高分辨质谱检测得到的精确质量数和元素组成结果与替诺福韦二吡呋酯的分子式相符,主要质谱碎片峰归属得到合理解释。从1H-NMR特征定量峰可以计算出富马酸与替诺福韦二吡呋酯结合比例。结论:本方法测定结果准确,为富马酸替诺福韦二吡呋酯的生产和鉴定提供可靠的数据。 展开更多
关键词 电子轰击质谱(EI—MS) 核磁共振(NMR) 富马酸 替诺福韦二吡呋酯 富马酸替诺福韦二吡呋酯(TDF) 核苷类逆转录酶抑制剂 结构分析 特征定量分析
原文传递
HIV感染前的药物预防 被引量:1
12
作者 张兴权 《中国病毒病杂志》 CAS 2011年第6期408-411,共4页
尽管全球人类免疫缺陷病毒(HIV)感染在目前已趋稳定并呈下降趋势,但2008年整个世界仍有2 700万新感染HIV的病人,因此预防HIV-1感染者向正常人群的传播仍是当务之急[1]。近些年来,HIV-1感染的预防研究集中在男子包皮环切、疫苗。
关键词 人类免疫缺陷病毒 核苷和核苷酸类逆转录酶抑制剂 感染前的预防
原文传递
HPLC-MS/MS法同时测定人血浆中替诺福韦艾拉酚胺及其代谢物替诺福韦的浓度和临床应用 被引量:6
13
作者 胡伟 杨乐婷 +1 位作者 蒋学华 王凌 《药物分析杂志》 CAS CSCD 北大核心 2019年第7期1200-1206,共7页
目的:建立快速、灵敏的高效液相色谱-串联质谱(HPLC-MS/MS)方法同时测定人血浆中替诺福韦艾拉酚胺(TAF)及其活性代谢产物替诺福韦(TFV)的浓度,并研究该药物在人体内的药动学特征。方法:采用Capcell pake ADME色谱柱(75 mm×2.1 mm,5... 目的:建立快速、灵敏的高效液相色谱-串联质谱(HPLC-MS/MS)方法同时测定人血浆中替诺福韦艾拉酚胺(TAF)及其活性代谢产物替诺福韦(TFV)的浓度,并研究该药物在人体内的药动学特征。方法:采用Capcell pake ADME色谱柱(75 mm×2.1 mm,5μm),以0.1%甲酸水溶液-甲醇为流动相,梯度洗脱,流速0.4mL·min^-1,进样量5μL;采用多反应监测(MRM),选择质荷比(m/z)477.3/346.1(TAF)、288.2/176.0(TFV)、484.3/346.1(内标1:TAF-d7)及294.2/182.0(内标2:TFV-d6)进行检测。结果:TAF与TFV质量浓度分别在0.1~400 ng·mL^-1及0.4~20 ng·mL^-1范围内线性关系良好,定量下限分别为0.100 0ng·mL^-1及0.400 0 ng·mL^-1,日内、日间精密度均小于9.0%,准确度分别为94.1%~99.2%和95.5%~112.8%。健康中国人服用富马酸替诺福韦艾拉酚胺片25 mg后,TAF主要药动学参数:Cmax=(207.97±61.08)ng·mL^-1,T1/2=(0.54±0.15)h,AUC0-∞=(126.07±42.67)h·ng·mL^-1;TFV主要药动学参数:Cmax=(8.76±1.46)ng·mL^-1,T1/2=(29.47±4.16)h,AUC0-∞=(193.19±45.75)h·ng·mL^-1。结论:该方法适用于TAF及其代谢产物TFV的血药浓度检测,并提供药动学参数。 展开更多
关键词 替诺福韦艾拉酚胺 替诺福韦 核苷类逆转录酶抑制剂 抗病毒药物 活性代谢物 磷酰胺酯前体药物 血浆药物浓度 药动学 高效液相色谱串联质谱法
原文传递
Route improvement of 3-substituted-4-(2-methylcyclohexyloxy)-6-phenethylpyridinone
14
作者 刘香宜 曹源源 +3 位作者 张羽 杨全志 王孝伟 刘俊义 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2014年第4期220-224,共5页
trans-3-Isopropyl-4-(2-methylcyclohexyloxy)-6-phenethylpyridin-2(1H)-one, as reverse transcriptase (NNRTIs), exhibited significant potent activity not only against wild-type HIV-1 strains but also on mutant stra... trans-3-Isopropyl-4-(2-methylcyclohexyloxy)-6-phenethylpyridin-2(1H)-one, as reverse transcriptase (NNRTIs), exhibited significant potent activity not only against wild-type HIV-1 strains but also on mutant strains. For furthering study this compound, the original synthetic route should be shorten to improve the total yield. In this report, we designed an efficient synthetic strategy to obtain the target compound with higher yield. 展开更多
关键词 hiv-1 Non-nucleoside reverse transcriptase inhibitors Route improvement
原文传递
Steered molecular dynamics simulations of protein-ligand interactions 被引量:2
15
作者 XU Yechun SHEN Jianhua LUO Xiaomin SHEN Xu CHEN Kaixian JIANG Hualiang 《Science China Chemistry》 SCIE EI CAS 2004年第5期355-366,共12页
Studies of protein-ligand interactions are helpful to elucidating the mechanisms of ligands, providing clues for rational drug design. The currently developed steered molecular dy- namics (SMD) is a complementary appr... Studies of protein-ligand interactions are helpful to elucidating the mechanisms of ligands, providing clues for rational drug design. The currently developed steered molecular dy- namics (SMD) is a complementary approach to experimental techniques in investigating the biochemical processes occurring at microsecond or second time scale, thus SMD may provide dynamical and kinetic processes of ligand-receptor binding and unbinding, which cannot be ac- cessed by the experimental methods. In this article, the methodology of SMD is described, and the applications of SMD simulations for obtaining dynamic insights into protein-ligand interactions are illustrated through two of our own examples. One is associated with the simulations of bind- ing and unbinding processes between huperzine A and acetylcholinesterase, and the other is concerned with the unbinding process of α-APAfrom HIV-1 reverse transcriptase. 展开更多
关键词 MOLECULAR DYNAMICS simulation steered MOLECULAR DYNAMICS simulation atomic force microscope avidin biotin huperzine A acetylcholinesterase hiv-1 reverse transcriptas NON-NUCLEOSIDE RT inhibitor.
原文传递
富马酸丙酚替诺福韦的工艺改进 被引量:2
16
作者 裴洪凤 刘成利 +2 位作者 张乃华 张立 张贵民 《中国医药工业杂志》 CAS CSCD 北大核心 2021年第4期499-502,506,共5页
本研究改进了富马酸丙酚替诺福韦(1)的合成工艺,并实现了公斤级放大。将替诺福韦一水合物(2)与亚磷酸三苯酯在甲苯中回流反应后,加入丙酮并调至pH 2~3,直接得(R)-9-(2-苯氧基膦酸甲氧基丙基)腺嘌呤(3)的无水结晶。3在混合溶剂中氯代后,... 本研究改进了富马酸丙酚替诺福韦(1)的合成工艺,并实现了公斤级放大。将替诺福韦一水合物(2)与亚磷酸三苯酯在甲苯中回流反应后,加入丙酮并调至pH 2~3,直接得(R)-9-(2-苯氧基膦酸甲氧基丙基)腺嘌呤(3)的无水结晶。3在混合溶剂中氯代后,与L-丙氨酸异丙酯盐酸盐反应,生成9-[(R)-2-[[(S)-[[(S)-1-(异丙氧基羰基)乙基]氨基]苯氧基氧膦基]甲氧基]丙基]腺嘌呤(5)。5与0.5倍摩尔量的富马酸在丙酮中成盐得到目标化合物1,化学纯度99.97%,手性纯度99.94%,总收率59%(以2计)。改进后的合成工艺生产成本低、操作简便,更适合工业化生产。 展开更多
关键词 富马酸丙酚替诺福韦 核苷酸类逆转录酶抑制剂 工艺改进 公斤级合成
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部